Best Pharma Stocks in India For Investment

Cipla

– Market capitalization: ₹73,770 crore – 5-year CAGR revenue growth: 11.5% – 5-year CAGR profit growth: 13.5% – Net profit margin: 21.19% – Return on equity: 13.02%

Images Credit Goes To  https://www.pexels.com/

Dr. Reddy’s Laboratories

– Market capitalization: ₹81,725 crore – 5-year CAGR revenue growth: 12.5% – 5-year CAGR profit growth: 14.5% – Net profit margin: 18.5% – Return on equity: 15.2%

Images Credit Goes To  https://www.pexels.com/

Sun Pharmaceutical Industries

– Market capitalization: ₹2.07 lakh crore – 5-year CAGR revenue growth: 10.5% – 5-year CAGR profit growth: 12.5% – Net profit margin: 18% – Return on equity: 16.5%

Images Credit Goes To  https://www.pexels.com/

Torrent Pharmaceuticals

– Market capitalization: ₹55,141 crore – 5-year CAGR revenue growth: 13% – 5-year CAGR profit growth: 14% – Net profit margin: 19% – Return on equity: 17%

Images Credit Goes To  https://www.pexels.com/

Biocon

– Market capitalization: ₹65,585 crore – 5-year CAGR revenue growth: 15% – 5-year CAGR profit growth: 20% – Net profit margin: 24.5% – Return on equity: 21.5%

Images Credit Goes To  https://www.pexels.com/

Alkem Laboratories

– Market capitalization: ₹36,516 crore – 5-year CAGR revenue growth: 14% – 5-year CAGR profit growth: 16% – Net profit margin: 18% – Return on equity: 19%

Images Credit Goes To  https://www.pexels.com/

Lupin

– Market capitalization: ₹49,511 crore – 5-year CAGR revenue growth: 12.5% – 5-year CAGR profit growth: 14.5% – Net profit margin: 17% – Return on equity: 18%

Images Credit Goes To  https://www.pexels.com/

Cadila Healthcare

– Market capitalization: ₹42,516 crore – 5-year CAGR revenue growth: 13% – 5-year CAGR profit growth: 15% – Net profit margin: 18.5% – Return on equity: 19%

Images Credit Goes To  https://www.pexels.com/

Cadila Healthcare

– Market capitalization: ₹42,516 crore – 5-year CAGR revenue growth: 13% – 5-year CAGR profit growth: 15% – Net profit margin: 18.5% – Return on equity: 19%

Images Credit Goes To  https://www.pexels.com/

Zydus Lifesciences

– Market capitalization: ₹38,516 crore – 5-year CAGR revenue growth: 12% – 5-year CAGR profit growth: 14% – Net profit margin: 17% – Return on equity: 18%

Images Credit Goes To  https://www.pexels.com/

Divi’s Laboratories

– Market capitalization: ₹23,516 crore – 5-year CAGR revenue growth: 15% – 5-year CAGR profit growth: 18% – Net profit margin: 20% – Return on equity: 22%

Images Credit Goes To  https://www.pexels.com/